Cargando…

Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR

Intrauterine growth restriction (IUGR) is a condition whereby a fetus is unable to achieve its genetically determined potential size. IUGR is a global health challenge due to high mortality and morbidity amongst affected neonates. It is a multifactorial condition caused by maternal, fetal, placental...

Descripción completa

Detalles Bibliográficos
Autores principales: Langmia, Immaculate M., Kräker, Kristin, Weiss, Sara E., Haase, Nadine, Schütte, Till, Herse, Florian, Dechend, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466995/
https://www.ncbi.nlm.nih.gov/pubmed/31024453
http://dx.doi.org/10.3389/fendo.2019.00215
_version_ 1783411219108986880
author Langmia, Immaculate M.
Kräker, Kristin
Weiss, Sara E.
Haase, Nadine
Schütte, Till
Herse, Florian
Dechend, Ralf
author_facet Langmia, Immaculate M.
Kräker, Kristin
Weiss, Sara E.
Haase, Nadine
Schütte, Till
Herse, Florian
Dechend, Ralf
author_sort Langmia, Immaculate M.
collection PubMed
description Intrauterine growth restriction (IUGR) is a condition whereby a fetus is unable to achieve its genetically determined potential size. IUGR is a global health challenge due to high mortality and morbidity amongst affected neonates. It is a multifactorial condition caused by maternal, fetal, placental, and genetic confounders. Babies born of diabetic pregnancies are usually large for gestational age but under certain conditions whereby prolonged uncontrolled hyperglycemia leads to placental dysfunction, the outcome of the pregnancy is an intrauterine growth restricted fetus with clinical features of malnutrition. Placental dysfunction leads to undernutrition and hypoxia, which triggers gene modification in the developing fetus due to fetal adaptation to adverse utero environmental conditions. Thus, in utero gene modification results in future cardiovascular programming in postnatal and adult life. Ongoing research aims to broaden our understanding of the molecular mechanisms and pathological pathways involved in fetal programming due to IUGR. There is a need for the development of effective preventive and therapeutic strategies for the management of growth-restricted infants. Information on the mechanisms involved with in utero epigenetic modification leading to development of cardiovascular disease in adult life will increase our understanding and allow the identification of susceptible individuals as well as the design of targeted prevention strategies. This article aims to systematically review the latest molecular mechanisms involved in the pathogenesis of IUGR in cardiovascular programming. Animal models of IUGR that used nutrient restriction and hypoxia to mimic the clinical conditions in humans of reduced flow of nutrients and oxygen to the fetus will be discussed in terms of cardiac remodeling and epigenetic programming of cardiovascular disease. Experimental evidence of long-term fetal programming due to IUGR will also be included.
format Online
Article
Text
id pubmed-6466995
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64669952019-04-25 Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR Langmia, Immaculate M. Kräker, Kristin Weiss, Sara E. Haase, Nadine Schütte, Till Herse, Florian Dechend, Ralf Front Endocrinol (Lausanne) Endocrinology Intrauterine growth restriction (IUGR) is a condition whereby a fetus is unable to achieve its genetically determined potential size. IUGR is a global health challenge due to high mortality and morbidity amongst affected neonates. It is a multifactorial condition caused by maternal, fetal, placental, and genetic confounders. Babies born of diabetic pregnancies are usually large for gestational age but under certain conditions whereby prolonged uncontrolled hyperglycemia leads to placental dysfunction, the outcome of the pregnancy is an intrauterine growth restricted fetus with clinical features of malnutrition. Placental dysfunction leads to undernutrition and hypoxia, which triggers gene modification in the developing fetus due to fetal adaptation to adverse utero environmental conditions. Thus, in utero gene modification results in future cardiovascular programming in postnatal and adult life. Ongoing research aims to broaden our understanding of the molecular mechanisms and pathological pathways involved in fetal programming due to IUGR. There is a need for the development of effective preventive and therapeutic strategies for the management of growth-restricted infants. Information on the mechanisms involved with in utero epigenetic modification leading to development of cardiovascular disease in adult life will increase our understanding and allow the identification of susceptible individuals as well as the design of targeted prevention strategies. This article aims to systematically review the latest molecular mechanisms involved in the pathogenesis of IUGR in cardiovascular programming. Animal models of IUGR that used nutrient restriction and hypoxia to mimic the clinical conditions in humans of reduced flow of nutrients and oxygen to the fetus will be discussed in terms of cardiac remodeling and epigenetic programming of cardiovascular disease. Experimental evidence of long-term fetal programming due to IUGR will also be included. Frontiers Media S.A. 2019-04-09 /pmc/articles/PMC6466995/ /pubmed/31024453 http://dx.doi.org/10.3389/fendo.2019.00215 Text en Copyright © 2019 Langmia, Kräker, Weiss, Haase, Schütte, Herse and Dechend. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Langmia, Immaculate M.
Kräker, Kristin
Weiss, Sara E.
Haase, Nadine
Schütte, Till
Herse, Florian
Dechend, Ralf
Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR
title Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR
title_full Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR
title_fullStr Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR
title_full_unstemmed Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR
title_short Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR
title_sort cardiovascular programming during and after diabetic pregnancy: role of placental dysfunction and iugr
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466995/
https://www.ncbi.nlm.nih.gov/pubmed/31024453
http://dx.doi.org/10.3389/fendo.2019.00215
work_keys_str_mv AT langmiaimmaculatem cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr
AT krakerkristin cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr
AT weisssarae cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr
AT haasenadine cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr
AT schuttetill cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr
AT herseflorian cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr
AT dechendralf cardiovascularprogrammingduringandafterdiabeticpregnancyroleofplacentaldysfunctionandiugr